✦ LIBER ✦

PIN20 A COST BENEFIT ANALYSIS OF ANTI-RETROVIRAL (ARVS) DRUGS IN THE TREATMENT OF HIV IN UGANDA

✍ Scribed by A. Mwanje; F. Kangenyi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN21 COST-BENEFIT ANALYSIS OF ANTI-INFL

✍ GL Colombo; A Ferro; M Vinci; M Zordan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Is the selection of patients for anti-re

✍ Neema Sofaer; Lydia Kapiriri; Lynn M. Atuyambe; Erasmus Otolok-Tanga; Ole Frithj 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 522 KB

PMH16 COST-BENEFIT ANALYSIS OF FOUR ANTI

✍ D Rosselli; R DeAntonio; R Córdoba 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

The Efficacy of Potent Anti-retroviral D

✍ J. Limoges; L. Poluektova; W. Ratanasuwan; J. Rasmussen; M. Zelivyanskaya; D.R. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 862 KB

PIN48 Cost-Efectiveness Analysis of Daru

✍ M. Santos; S. Stenut; W. Ferraq; J.C. Legrand; P. Tilleul; I. Borget 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PIN20 COST-MINIMIZATION ANALYSIS OF VORI

✍ A Domínguez-Gil Hurlé; I Martín Herranz; M García Vargas; J Rejas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB